{
  "docId": "019de070-699f-77f8-bbbb-b770da56fde3",
  "docSlug": "068a25e0403b2abb3acbdc102f073cd6",
  "documentTitle": "BioNTech | Results Presentation Deck | 25 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "deck",
  "documentKindLabel": "Deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 25,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 8,
  "notes": "The slide uses a two-part structure to separate historical balance sheet data from forward-looking guidance.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-699f-77f8-bbbb-b770da56fde3/23",
  "deckHref": "/decks/019de070-699f-77f8-bbbb-b770da56fde3",
  "deckJsonHref": "/decks/019de070-699f-77f8-bbbb-b770da56fde3.json",
  "deckAnchorHref": "/decks/019de070-699f-77f8-bbbb-b770da56fde3#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.22,
        "y": 0.4
      },
      "kind": "list",
      "text": "On August 28, 2020, BioNTech and a fund associated with Temasek closed a €100.0 million ($119.2 million) investment in a 4-year mandatory convertible note. Temasek and another accredited investor contributed a private investment of €123.9 million ($146.0 million) in ordinary shares.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "196f9a5f-7175-4318-937b-2faba16e12ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.75,
        "x": 0.22,
        "y": 0.22
      },
      "kind": "list",
      "text": "Cash and cash equivalents of €990.5 million ($1,159.7 million) as of September 30, 2020. On July 27, 2020, BioNTech closed an underwritten offering of 5,500,000 ADSs for gross proceeds of €435.0 million ($511.5 million).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57d6f4eb-9805-46c5-8077-e4e365822965",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.75,
        "x": 0.22,
        "y": 0.56
      },
      "kind": "list",
      "text": "On September 15, 2020 BioNTech secured grant funding of up to €375.0 million ($439.1 million) in milestone-based funding from the BMBF to support and accelerate the BNT162 vaccine program execution.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "919af294-8995-470f-b347-4aa70b0dd681",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.75,
        "x": 0.22,
        "y": 0.77
      },
      "kind": "list",
      "text": "BioNTech expects net cash used in operating activities and for purchases of property, plant and equipment to be within the previously guided range of €450 million and €600 million for the full year 2020.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c58bb055-5f75-4732-a715-ba8ab2ef3301",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.21,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1 Amounts translated using the exchange rate published by the German Central Bank (Deutsche Bundesbank) in effect as of the date of transaction, if closed; otherwise as of September 30, 2020. 2 German Federal Ministry of Education (Bundesministerium für Bildung und Forschung)",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f949be10-65bc-4b55-8fdc-751b71cd969b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "Third Quarter 2020 Financial Results (unaudited) – Balance Sheet",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c5e5571-3fba-45fb-938e-86bbc57e119f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 23,
      "from": 22,
      "beatId": "f2f3d40a-5c41-471a-9e39-5bfb9ea0f9b3",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "Third Quarter 2020 Financial Results",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}